Q97858921

Summary

Q97858921 is a committee group motion^[1].

Key Facts

• Q97858921 authored Gunilla Wahlén^[2].
• Q97858921 authored Ingrid Burman^[3].
• Q97858921 authored Ulla Hoffmann^[4].
• Q97858921 authored Kalle Larsson^[5].
• Q97858921 authored Elina Linna^[6].
• Q97858921's instance of is recorded as committee group motion^[7].
• Q97858921's part of the series is recorded as motions of the 2005-2006 legislative session of the Riksdag^[8].
• Q97858921's language of work or name is recorded as Swedish^[9].
• Q97858921 was released on +2005-09-29T00:00:00Z^[10].
• Q97858921's main subject is medication^[11].
• Q97858921's work available at URL is recorded as http://data.riksdagen.se/dokument/GT02So358^[12].
• Q97858921's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GT02So358^[13].
• Q97858921's applies to jurisdiction is recorded as Sweden^[14].
• Q97858921's legal citation of this text is recorded as Mot. 2005/06:So358^[15].
• Q97858921's title is recorded as Läkemedel^[16].
• Q97858921's maintained by WikiProject is recorded as Project Riksdagen's documents^[17].
• Q97858921's copyright status is recorded as public domain^[18].
• Q97858921's legislative committee is recorded as Committee on Health and Welfare^[19].

Body

Definition and Type

Q97858921's instance of is recorded as committee group motion^[7].